Pruritus and Tense Bullae After Discontinuation of Pembrolizumab in a Patient With Renal Cell Carcinoma

JAMA. 2020 Oct 13;324(14):1453-1454. doi: 10.1001/jama.2020.10159.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Antibodies, Monoclonal, Humanized / adverse effects*
  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Biopsy
  • Blister / chemically induced*
  • Blister / pathology
  • Carcinoma, Renal Cell / complications
  • Carcinoma, Renal Cell / drug therapy*
  • Female
  • Humans
  • Middle Aged
  • Pemphigoid, Bullous / chemically induced
  • Pemphigoid, Bullous / diagnosis*
  • Programmed Cell Death 1 Receptor / antagonists & inhibitors*
  • Pruritus / chemically induced*
  • Pruritus / pathology
  • Skin / pathology

Substances

  • Antibodies, Monoclonal, Humanized
  • Programmed Cell Death 1 Receptor
  • pembrolizumab